Clinical Info

Overview

Doctor with patient

Through strategic alliances & scientific collaborations with companies such as STORZ Medical AG, CuraMedix is targeting a fundamental understanding of the effects of EPAT® in both acute and chronic musculoskeletal conditions. Extensive research into the biological mechanisms and cellular effects of acoustic pressure waves has resulted in the development of EPAT® technologies. This proprietary technology is based on unique sets of acoustic pressure waves that stimulate healing. CuraMedix’s dedication to this endeavor will transform the way we discover, benefiting our medical professional partners, patients and the research community supporting them.

Providing the medical community with comprehensive and relevant clinical information regarding CuraMedix products is an important part of the company’s mission.

Clinical Trials

If you are interested in participating in a current or future CuraMedix clinical trial,
please contact: clinicaltrials@curamedix.com

Ask The Doctor

If you a have clinical application or treatment protocol question,
please contact: rob.gordon@curamedix.com

Robert G. Gordon, MD, F.R.C.S.C.

Orthopaedic Surgeon, Division of Orthopaedic Surgery,
Musculoskeletal Health & Arthritis Program, University Health Network

Dr. Gordon is the Director of the Institute for the Non-Surgical Treatment of Bone, Heel and Joint Pain, and holds memberships in a variety of medical and professional societies and associations.

Dr. Gordon’s vast experience in treating musculoskeletal and sports related injuries non-invasively, had lead to the role of recent past President for the International Society of Musculoskeletal Shockwave Therapy. He has authored several scientific papers and serves as a medical consultant to many collegiate, semi-professional and professional athletes and sports teams throughout North America.